Navigation Links
Analog Devices Healthcare Director Delivers Speech on Role of Analog Semiconductors in Next-Generation Portable Medical Equipment : ADI's Pat O'Doherty is a featured speaker at electronica 2008.
Date:11/11/2008

During his speech today at electronica 2008, Pat O’Doherty, healthcare segment director for Analog Devices, Inc. (ADI), spotlighted how sophisticated healthcare semiconductor technology is paving the way for the development of increasingly smaller and more powerful medical devices for use in both the home and doctors’ offices. These types of devices include those that check glucose levels and blood pressure, check heart rates, monitor activity levels, and distribute medication for pain management. For patients, the benefits of smaller, portable devices translate into easier access to care, less hospital visits, and reduced medical costs.

MUNICH, Germany (Business Wire EON) November 11, 2008 -- O'Doherty discussed how the growing demand for point-of-care and home-use medical devices is making systems requirements progressively complex and demanding for medical equipment designers who must reduce the size, improve ease of use, and increase the performance of next-generation portable medical devices. These new system-level demands mean that analog semiconductor manufacturers must rise to the challenge of developing breakthrough building-block ICs that make the design of next-generation products possible. O'Doherty also underscored how developing future innovative capabilities for medical devices is increasingly dependent on the continuous and effective sharing of information between both system and analog integrated circuit designers.

In addition, O'Doherty explained how the ability of semiconductor manufacturers to develop a deep system-level understanding and provide maximum value to their customers is becoming one of the most important competitive dimensions in the analog semiconductor arena.

About Pat O'Doherty

As healthcare segment director at Analog Devices, Pat O'Doherty leads the company's business development and marketing efforts for tech
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Varian, Inc. Acquires Analogix Business
2. Video: TI unveils industrys first family of complete analog front ends for superior ultrasound systems
3. New AnyTrack GPS Devices Track Assets Indoors, Outdoors or Hidden
4. Design Resource Extends Support for Orthopaedic and Cardiovascular Devices
5. FDA Approves SYMLIN Pen-Injector Devices Offering Convenience and Accuracy for SYMLIN Use
6. HealthShares(TM) Announces Change to the HealthShares(TM) Cardio Devices Index
7. Nationwide independent Taser study results suggest devices are safe
8. Brain measurements could lead to better devices to move injured or artificial limbs
9. Do women fare worse with some heart devices?
10. QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cardio Devices, and the HealthShares(TM) Orthopedic Repair Indexes
11. DeviceSpace Career Fair Opens Doors for Hundreds of Medical Device and Diagnostics Career Candidates
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 Analog Devices Healthcare Director Delivers Speech on Role of Analog Semiconductors in Next-Generation Portable Medical Equipment :  ADI's Pat O'Doherty is a featured speaker at electronica 2008. 
(Date:6/29/2015)... ... June 29, 2015 , ... Scientists from the Icahn School ... complete genomes by combining high-throughput DNA sequencing with genome mapping. The methodology enabled ... with human disease, but previously difficult to detect. The study was published today ...
(Date:6/29/2015)... Fernando Valley, CA (PRWEB) , ... June 29, 2015 , ... ... non-invasive treatments designed to lift and tighten sagging skin. Ulthera is a special treatment ... surgery. Instead, it uses ultrasound technology to gently stimulate collagen production. Ulthera is highly ...
(Date:6/29/2015)... ... June 29, 2015 , ... The ... Chemical Technology of The Hong Kong Polytechnic University (PolyU) has developed a new ... of edible oils has been a long-term issue in food safety, and becomes ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... company serving the Twin Cities area, provides money-saving tactics during a season of ... Twin Cities’ residents, addressing water conservation and other economical practices. , According to ...
(Date:6/29/2015)... ... , ... BaliniSports has been announced as an official sponsor and apparel provider ... This year’s contestants will be wearing pieces from the BaliniSports collection during practice sessions ... on to represent the state in the Miss Teen USA competition. , “BaliniSports ...
Breaking Medicine News(10 mins):Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 2Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 4Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 2Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 3Health News:PolyU develops a new method for rapid authentication of edible oils and screening of gutter oils 2Health News:Save Energy: MSP Plumbing, Heating & Air Endorses Efficiency 2Health News:Save Energy: MSP Plumbing, Heating & Air Endorses Efficiency 3Health News:BaliniSports Announced as Sponsor of the Miss Teen Nevada 2016 Competition 2
... study, published online in the Journal of Allergy ... therapies against childhood eczema in attempt to reduce the ... conducted by the University of Melbourne, Monash University and ... 8500 people who are part of the Tasmanian Longitudinal ...
... Dental researchers at the University of Washington have reported ... treated with the topical syrup xylitol, a naturally occurring ... General Session of the International Association for Dental Research. ... of the Marshall Islands, children 6 to 15 months ...
... mechanism present early in life predisposes people to worry, ... The brains of people who suffer from anxiety and ... show signs of being anxious even in situations considered ... Wisconsin School of Medicine and Public Health. , ...
... or tooth decay, continues to be the most prevalent ... and socio-economic consequences. It leads to the loss of ... necrosis of the subjacent dental pulp. In the U.S. ... with failure rates of up to 60%. Hence, there ...
... July 4 /Xinhua-PRNewswire-FirstCall/ -- Mindray,Medical International Limited (NYSE: ... of medical devices worldwide, today announced it has ... audited financial statements for,the fiscal year ended December ... (the "SEC") in accordance with United States,requirements. Mindray,s ...
... July 3 The July 5 issue of ... of Istanbul,on Organ Trafficking and Transplant Tourism, an ... May 2, 2008, at an,International Summit of more ... scholars from 78 countries and 20,international organizations. A ...
Cached Medicine News:Health News:Anxiety, Shyness May Be Long-Lasting Traits 2Health News:Novel hydrogel systems for dentin regeneration 2Health News:Mindray Announces 20-F Filing 2Health News:Commentary in The Lancet on the Declaration of Istanbul Sees Organ Transplantation Worldwide Threatened by Organ Trafficking and Transplant Tourism and Commercialism 2
(Date:6/29/2015)... , June 29, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... added to the Russell 1000 Index, effective June 26, ... the large-cap segment of the U.S. equity universe. It ... includes approximately 1000 of the largest securities based on ... membership. "We are pleased to be added ...
(Date:6/29/2015)... Axxess , an industry leader in ... vendor accredited by the American Nursing Credentialing Center – ... agencies select the right revenue cycle management (RCM) system ... business. Research by American Health Information Management ... a decrease in productivity of 54.4 - 69 percent ...
(Date:6/29/2015)... 29, 2015  Arbor Solution has added another ... high-powered, multi-functional M2150 offers two platforms: ... Core i5-4402E 1.6 GHz processor and i5-4422E ... and computing performance. Integrated Intel® HD Graphics 4600 ... suited for graphics-intense applications in operating rooms, clinical ...
Breaking Medicine Technology:ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3Axxess Releases eGuide for Home Health Agencies, Revenue Cycle Management: What You Must Do Now - to Succeed! 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3
... N.J., July 05, 2007 /PRNewswire/ -- Results ... open-label, Phase,3 study showed that 77 percent ... 600 mg tablets with,100 mg ritonavir (PREZISTA/r) ... of antiretroviral (ARV) agents, reached a,plasma viral ...
... 2007 - ZIOPHARM,Oncology, Inc. (NASDAQ: ZIOP) announces ... II trial of ZIO-201 (isophosphoramide mustard,- IPM) ... at the,European Society of Medical Oncology (ESMO) ... The abstract entitled, "Phase-I/II,Study of IPM (ZIO-201) ...
Cached Medicine Technology:New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 3New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 4New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 5New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 7New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 8Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 2Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 3
Nordan tying forceps, straight, titanium, 6.5 mm tying platforms....
Harms-Tuebingen tying forceps, straight, 6 mm tying platforms....
Castroviejo straight tying forceps, straight shafts, 5 mm tying platforms, wide handle....
Shepard tying forceps, round curved platform 8 mm, 8.5 cm....
Medicine Products: